Skip to main content
. 2021 Apr 19;14:381–392. doi: 10.2147/JAA.S305114

Figure 2.

Figure 2

Proportion of HCPs, patients and caregivers who successfully administered tezepelumab via APFS or AI in (A) the overall population and (B) adolescents only. Values in the bars represent the number of patients who administered study drug successfully out of the total number of patients who received or attempted to receive study drug.

Abbreviations: AI, autoinjector; APFS, accessorized pre-filled syringe; HCP, healthcare professional.